for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

キンバリークラーク・コーポレーション

KMB.N

現在値

127.41USD

変化

-0.61(-0.48%)

出来高

475,789

本日のレンジ

127.37

 - 

129.64

52週レンジ

108.81

 - 

144.53

∙ 約20分前の相場を表示しています。

適時開示

Kimberly-Clark Reports Q4 Profit Beat

Jan 25 (Reuters) - Kimberly-Clark Q4 gross profit USD 1,627 million.:.

Kimberly-Clark Announces Third Quarter 2022 Results

Oct 25 (Reuters) - Kimberly-Clark Corp <KMB.N>::KIMBERLY-CLARK ANNOUNCES THIRD QUARTER 2022 RESULTS.Q3 EARNINGS PER SHARE $1.38.Q3 ADJUSTED EARNINGS PER SHARE $1.40.Q3 SALES ROSE 1 PERCENT TO $5.1 BILLION.QTRLY PERSONAL CARE SEGMENT Q3 SALES OF $2.6 BILLION DECREASED 1%.QTRLY RESULTS WERE IMPACTED BY $360 MILLION OF HIGHER INPUT COSTS.QTRLY CONSUMER TISSUE SEGMENT Q3 SALES OF $1.6 BILLION INCREASED 2 PERCENT.CHANGES IN FOREIGN CURRENCY EXCHANGE RATES REDUCED SALES 4 PERCENTN QUARTER.SEES FY NET SALES INCREASE 2 TO 4 PERCENT WITH ORGANIC SALES GROWTH OF 5 TO 7 PERCENT.CONTINUES TO TARGET FULL-YEAR 2022 ORGANIC SALES GROWTH OF 5 TO 7 PERCENT.SEES FY 2022 ADJUSTED EARNINGS PER SHARE AT LOWER END OF $5.60 TO $6.00 RANGE.KIMBERLY-CLARK SEES FOREIGN CURRENCY EXCHANGE RATES UNFAVORABLE 3% TO 4% ON NET SALES WITH MID-TO HIGH-SINGLE DIGIT IMPACT ON OPERATING PROFIT IN FY.SEES FY CAPITAL SPENDING $0.9 TO $1.0 BILLION.Q3 EARNINGS PER SHARE VIEW $1.44, REVENUE VIEW $5.01 BILLION -- REFINITIV IBES DATA.

Ansell Says Decision Made To Exit Russian Operations

Aug 23 (Reuters) - Ansell Ltd <ANN.AX>::DECISION MADE TO EXIT OUR RUSSIAN OPERATIONS.FINAL DIVIDEND OF US31.20 CENTS.FY SALES $1,952.1 MILLION VERSUS $2,026.9 MILLION.ANSELL CONSIDERS LAWSUIT ISSUED IN U.S. AGAINST ANSELL AND KIMBERLY-CLARK "WITHOUT MERIT" AND INTENDS TO DEFEND.FY EBIT $228.1 MILLION VERSUS $338.0 MILLION.RUSSIA'S INVASION OF UKRAINE CAUSED CO TO RECONSIDER VIABILITY OF BUSINESS IN RUSSIA.EXIT FROM RUSSIA WILL MEAN THAT $9M EBIT IN FY22 WILL NOT REOCCUR IN FY23.SEES FY23 EFFECTIVE TAX RATE TARGETED TO BE IN RANGE OF 21.5%-23.5%.INTEREST COSTS EXPECTED TO INCREASE TO $22-23M FOR FY23.MADE ULTIMATE DECISION BEING TO EXIT COMMERCIAL AND MANUFACTURING OPERATIONS IN RUSSIA.FY23 EPS EXPECTED TO BE IN RANGE OF US115 CENTS - US135 CENTS.WILL MAINTAIN A CAUTIOUS STANCE ON HEADCOUNT.EXTERNAL ENVIRONMENT REMAINS SUPPORTIVE FOR CONTINUED DEMAND FOR OUR PRODUCTS AND IS EXPECTED TO DRIVE VOLUME GROWTH FOR ALL OUR SBUS.EXAM/SU PRICE NORMALISATION IS ANTICIPATED TO RESULT IN OVERALL SALES DECLINE IN FY23.BRIGHTWAY PRODUCTS HAVE NEVER REPRESENTED "MORE THAN A VERY SMALL PERCENTAGE" OF ANSELL'S TOTAL PURCHASES FROM THIRD PARTIES.

Kimberly-Clark Announces Second Quarter 2022 Results

July 26 (Reuters) - Kimberly-Clark Corp <KMB.N>::KIMBERLY-CLARK ANNOUNCES SECOND QUARTER 2022 RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $1.34.Q2 EARNINGS PER SHARE $1.29.Q2 SALES ROSE 7 PERCENT TO $5.1 BILLION.Q2 EARNINGS PER SHARE VIEW $1.32, REVENUE VIEW $4.97 BILLION -- REFINITIV IBES DATA.NOW TARGETING FULL-YEAR 2022 ORGANIC SALES GROWTH OF 5 TO 7 PERCENT COMPARED TO PRIOR OUTLOOK OF 4 TO 6 PERCENT.DILUTED NET INCOME PER SHARE FOR 2022 IS EXPECTED TO BE $5.67 TO $6.10.MAINTAINS ADJUSTED EARNINGS PER SHARE RANGE OF $5.60 TO $6.00 FOR 2022.FY2022 EARNINGS PER SHARE VIEW $5.73 -- REFINITIV IBES DATA.Q2 SALES PERSONAL CARE SEGMENT OF $2.7 BILLION INCREASED 8 PERCENT.CONSUMER TISSUE SEGMENT Q2 SALES OF $1.5 BILLION, INCREASED 8 PERCENT.SAYS "LEVERAGING PRICE AND COST DISCIPLINE TO MITIGATE MACRO HEADWINDS FOR MARGIN IMPROVEMENT OVER TIME".SEES FOREIGN CURRENCY EXCHANGE RATES UNFAVORABLE APPROXIMATELY 3 PERCENT IN 2022.GIVEN CURRENT COST OUTLOOK, EXPECT ADJUSTED EARNINGS PER SHARE TO BE AT LOWER END OF RANGE IN 2022.

Kimberly-Clark Announces First Quarter 2022 Results

April 22 (Reuters) - Kimberly-Clark Corp <KMB.N>::KIMBERLY-CLARK ANNOUNCES FIRST QUARTER 2022 RESULTS.Q1 ADJUSTED EARNINGS PER SHARE $1.35.Q1 EARNINGS PER SHARE $1.55.Q1 SALES ROSE 7 PERCENT TO $5.1 BILLION.NOW TARGETING FULL-YEAR 2022 ORGANIC SALES GROWTH OF 4 TO 6 PERCENT, COMPARED TO OUR PRIOR OUTLOOK OF 3 TO 4 PERCENT.PERSONAL CARE SEGMENT Q1 SALES OF $2.7 BILLION INCREASED 11 PERCENT.EXPECTS FY ADJUSTED EARNINGS PER SHARE OF $5.60 TO $6.00.CONSUMER TISSUE SEGMENT Q1 SALES OF $1.6 BILLION INCREASED 4 PERCENT.CONTINUE TO TAKE NECESSARY ACTIONS TO MITIGATE MACRO HEADWINDS AND REMAIN COMMITTED TO IMPROVING OUR MARGINS OVER TIME.KIMBERLY-CLARK QTRLY RESULTS WERE IMPACTED BY $470 MILLION OF HIGHER INPUT COSTS, DRIVEN BY PULP AND POLYMER-BASED MATERIALS, DISTRIBUTION AND ENERGY COSTS.Q1 EARNINGS PER SHARE VIEW $1.23, REVENUE VIEW $4.90 BILLION -- REFINITIV IBES DATA.FY2022 EARNINGS PER SHARE VIEW $5.76, REVENUE VIEW $19.85 BILLION -- REFINITIV IBES DATA.SEES 2022 NET SALES INCREASE 2 TO 4 PERCENT.

Kimberly-Clark CFO Maria Henry To Retire, Nelson Urdaneta To Succeed

March 22 (Reuters) - Kimberly-Clark Corp <KMB.N>::KIMBERLY-CLARK ANNOUNCES MARIA HENRY TO RETIRE; NELSON URDANETA NAMED CFO.KIMBERLY-CLARK CORP - TO ENSURE A SMOOTH TRANSITION, HENRY WILL CONTINUE AT KIMBERLY-CLARK IN AN ADVISORY CAPACITY UNTIL SEPT. 1.

Kimberly-Clark Announces Year-End 2021 Results And 2022 Outlook

Jan 26 (Reuters) - Kimberly-Clark Corp <KMB.N>::KIMBERLY-CLARK ANNOUNCES YEAR-END 2021 RESULTS AND 2022 OUTLOOK.Q4 ADJUSTED EARNINGS PER SHARE $1.30.Q4 EARNINGS PER SHARE $1.06.Q4 SALES ROSE 3 PERCENT TO $5.0 BILLION.Q4 EARNINGS PER SHARE VIEW $1.24, REVENUE VIEW $4.89 BILLION -- REFINITIV IBES DATA.QTRLY PERSONAL CARE SEGMENT SALES OF $2.6 BILLION INCREASED 12 PERCENT.QTRLY CONSUMER TISSUE SEGMENT SALES OF $1.6 BILLION DECREASED 10 PERCENT.NET SALES IN 2022 ARE EXPECTED TO INCREASE 1 TO 2 PERCENT, INCLUDING ORGANIC SALES GROWTH OF 3 TO 4 PERCENT.DILUTED NET INCOME PER SHARE FOR 2022 IS ANTICIPATED TO BE $5.60 TO $6.00.SEES FY 2022 CAPITAL SPENDING OF $1,000 MILLION TO $1,100 MILLION.BOARD OF DIRECTORS HAS APPROVED A 1.8 PERCENT INCREASE IN QUARTERLY DIVIDEND.FY2022 EARNINGS PER SHARE VIEW $6.72, REVENUE VIEW $20.03 BILLION -- REFINITIV IBES DATA.COMMITTED TO RECOVERING MARGINS TO PRE-PANDEMIC LEVELS OVER TIME, AND ARE OPTIMISTIC ABOUT GRADUAL IMPROVEMENT LATER IN YEAR.

Kimberly-Clark Sees FY Adjusted EPS Between $6.05 And $6.25

Oct 25 (Reuters) - Kimberly-Clark Corp <KMB.N>::KIMBERLY-CLARK ANNOUNCES THIRD QUARTER 2021 RESULTS.SEES FY ADJUSTED EARNINGS PER SHARE $6.05 TO $6.25.Q3 ADJUSTED EARNINGS PER SHARE $1.62.Q3 EARNINGS PER SHARE $1.39.Q3 SALES ROSE 7 PERCENT TO $5.0 BILLION.NOW TARGETING FULL-YEAR 2021 ORGANIC SALES DECLINE OF 1 TO 2 PERCENT AND ADJUSTED EARNINGS PER SHARE OF $6.05 TO $6.25.PERSONAL CARE SEGMENT Q3 SALES OF $2.7 BILLION INCREASED 14 PERCENT.UPDATED EARNINGS OUTLOOK REFLECTS SIGNIFICANTLY HIGHER INPUT COST INFLATION.CONSUMER TISSUE SEGMENT Q3 SALES OF $1.5 BILLION DECREASED 5 PERCENT.IN QUARTER CHANGES IN FOREIGN CURRENCY EXCHANGE RATES INCREASED SALES 1 PERCENT.NOW PLANS FOR FULL-YEAR REPURCHASES OF APPROXIMATELY $400 MILLION, AT LOW END OF PREVIOUS RANGE OF $400 TO $450 MILLION.KIMBERLY-CLARK - QTRLY EARNINGS NEGATIVELY IMPACTED BY SIGNIFICANT INFLATION & SUPPLY CHAIN DISRUPTIONS THAT INCREASED COSTS BEYOND WHAT WE ANTICIPATED.TAKING FURTHER ACTION, INCLUDING ADDITIONAL PRICING AND ENHANCED COST MANAGEMENT, TO MITIGATE HEADWINDS.FOR FY 2021 ADJUSTED OPERATING PROFIT EXPECTED TO DECLINE 20 TO 22 PERCENT YEAR-ON-YEAR.SEES 2021 KEY COST INPUTS EXPECTED TO INCREASE $1,400 TO $1,500 MILLION.FOR FY 2021 SEES CAPITAL SPENDING OF $1,000 TO $1,100 MILLION.SEES FY NET SALES INCREASE 1 TO 2 PERCENT.Q3 EARNINGS PER SHARE VIEW $1.65, REVENUE VIEW $4.99 BILLION -- REFINITIV IBES DATA.FY2021 EARNINGS PER SHARE VIEW $6.70, REVENUE VIEW $19.42 BILLION -- REFINITIV IBES DATA.

Kimberly-Clark Declares Regular Qtrly Dividend Of $1.14 Per Share

Aug 2 (Reuters) - Kimberly-Clark Corp <KMB.N>::DECLARED A REGULAR QUARTERLY DIVIDEND OF $1.14 PER SHARE.

Kimberly-Clark Sees FY Adjusted Earnings Per Share $6.65 To $6.90

July 23 (Reuters) - Kimberly-Clark Corp <KMB.N>::KIMBERLY-CLARK ANNOUNCES SECOND QUARTER 2021 RESULTS.SEES FY ADJUSTED EARNINGS PER SHARE $6.65 TO $6.90.Q2 ADJUSTED EARNINGS PER SHARE $1.47.Q2 EARNINGS PER SHARE $1.19.Q2 SALES $4.7 BILLION VERSUS REFINITIV IBES ESTIMATE OF $4.76 BILLION.Q2 EARNINGS PER SHARE ESTIMATE $1.71 -- REFINITIV IBES DATA.NOW TARGETING FULL-YEAR 2021 ORGANIC SALES DECLINE OF 0 TO 2 PERCENT AND ADJUSTED EARNINGS PER SHARE OF $6.65 TO $6.90.UPDATED EARNINGS OUTLOOK REFLECTS SIGNIFICANTLY HIGHER INPUT COST INFLATION AND LOWER SALES VOLUMES.Q2 REFLECTS CONTINUED PANDEMIC-DRIVEN VOLATILITY.FACING SIGNIFICANTLY HIGHER INPUT COSTS AND A REVERSAL IN CONSUMER TISSUE VOLUMES FROM RECORD GROWTH IN YEAR AGO PERIOD.MOVED DECISIVELY TO TAKE PRICING ACTIONS TO MITIGATE INFLATIONARY HEADWINDS AND CONTINUE TO PRUDENTLY MANAGE COSTS.CONSUMER TISSUE SEGMENT Q2 SALES OF $1.4 BILLION DECREASED 13 PERCENT.SEES 2021 NET SALES INCREASE 1 TO 4 PERCENT.SEES 2021 ORGANIC SALES DECLINE 0 TO 2 PERCENT.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up